All events are in Central time unless specified.

CBC/RBC seminar - Dr. Grace Guo, Rutgers Univ.

Bile Acids, FXR, and FGF15/19 in Liver Diseases Development

Date: Time: 4:00 pm–5:00 pm
via Zoom presentation
Directions: https://unl.zoom.us/j/97586523724
Meeting ID: 975 8652 3724 Passcode: 868191
Contact: Diana Bonham, (402) 472-2932, dbonham2@unl.edu
Bile acids (BAs) are evolutionally conserved molecules synthesized in the liver from cholesterol and have been shown to be essential for lipid homeostasis. BAs regulate a variety of metabolic functions via modulating nuclear and membrane receptors. Farnesoid X receptor (FXR) is the most important nuclear receptor for maintaining BA homeostasis. FXR plays a tissue-specific role in suppressing BA synthesis and promoting BA enterohepatic circulation. Disruption of FXR in mice have been implicated in liver diseases commonly occurring in humans, including cholestasis, non-alcoholic fatty liver diseases, and hepatocellular carcinoma. Strategically targeting FXR activity has been rapidly used to develop novel therapies for the prevention and/or treatment of cholestasis and non-alcoholic steatohepatitis. However, cautions need to be taken for adverse side effects.

https://biochem.unl.edu

Download this event to my calendar

This event originated in Biochemistry.